ArchiMed acquires DIESSE Diagnostica Senese for €14.5 million

MED II, managed by ArchiMed SAS, completed the acquisition of DIESSE Diagnostica Senese S.p.A. from Orphée SA and founders for €14.5 million on May 13, 2019. The deal included 13.5 million Class A shares for €13.3 million.

“MED II, managed by ArchiMed SAS completed the acquisition of DIESSE Diagnostica Senese S.p.A. from Orphée SA and founders for €14.5 million.”marketscreener.com

• 2 sources
• marketscreener.comMED II, managed by ArchiMed SAS completed the acquisition of DIESSE Diagnostica Senese S.p.A. from Orphée SA and founders for €14.5 million.S&P Capital IQMay 12, 2019
• lawyer-monthly.comArchiMed acquires In Vitro Diagnostics - Lawyer MonthlyAndrew PalmerAug 6, 2019

Summarized from public sources; check the original articles before acting on it.